A reporter system for Epstein-Barr virus (EBV) lytic replication: Anti-EBV activity of the broad anti-herpesviral drug artesunate
- 1 May 2011
- journal article
- Published by Elsevier BV in Journal of Virological Methods
- Vol. 173 (2), 334-339
- https://doi.org/10.1016/j.jviromet.2011.03.005
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (MA 1289/7-1)
- HHV-6 Foundation (M.M. 2009)
- Bayerische Forschungsstiftung (4SC-2010)
This publication has 16 references indexed in Scilit:
- Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.Cancer Biology & Therapy, 2009
- Drug targets in herpes simplex and Epstein Barr Virus infections.Infectious Disorders - Drug Targets, 2009
- The Antiviral Activities of Artemisinin and ArtesunateClinical Infectious Diseases, 2008
- Phosphoacceptor Site S173 in the Regulatory Domain of Epstein-Barr Virus ZEBRA Protein Is Required for Lytic DNA Replication but Not for Activation of Viral Early GenesJournal of Virology, 2007
- Epstein-Barr Virus mRNA Export Factor EB2 Is Essential for Production of Infectious VirusJournal of Virology, 2002
- Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJournal of Molecular Medicine, 2001
- Recombinant Green Fluorescent Protein-Expressing Human Cytomegalovirus as a Tool for Screening Antiviral AgentsAntimicrobial Agents and Chemotherapy, 2000
- Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cellsProceedings of the National Academy of Sciences of the United States of America, 1998
- The lytic transition of Epstein-Barr virus is imitated by recombinant B-cellsArchiv für die gesamte Virusforschung, 1993
- Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells.Molecular and Cellular Biology, 1988